Evidence map›Paper›PMID 29563620›Full record

ArticleNature immunology2018

IL-17-receptor-associated adaptor Act1 directly stabilizes mRNAs to mediate IL-17 inflammatory signaling.

Tomasz Herjan, Lingzi Hong, Jodi Bubenik, Katarzyna Bulek, Wen Qian, Caini Liu, Xiao Li, Xing Chen, Hui Yang, Suidong Ouyang and 12 more

Open access · greenAbstract read
In one paragraph

Article in Nature immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 1 synthesis or guideline pooled it, 123 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. N4BP1 acts as a potent negative regulator of IL-17 signaling by blocking the translation of Act1 mRNA.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  8. Review
  9. Article
  10. Phlorotannins fromMarine drugs · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. The IL-17 pathway intertwines with neurotrophin and TLR/IL-1R pathways since its domain shuffling origin.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  18. Review
  19. Regional variations in allergen-induced airway inflammation correspond to changes in soluble guanylyl cyclase heme and expression of heme oxygenase-1.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 2 countries.

Tomasz HerjanDepartment of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Lingzi HongDepartment of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Jodi BubenikDepartment of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Katarzyna BulekDepartment of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Wen QianDepartment of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Caini LiuDepartment of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Xiao LiDepartment of Genetics, Stanford University School of Medicine, Stanford, California, USA.
Xing ChenDepartment of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Hui YangDepartment of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Suidong OuyangDepartment of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Hao ZhouDepartment of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.ORCID 0000-0001-9109-2489
Junjie ZhaoDepartment of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Kommireddy VasuDepartment of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Eric CockmanDepartment of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Mark AronicaDepartment of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Kewal AsosinghDepartment of Pathobiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
Donny D LicatalosiCenter for RNA Molecular Biology, Department of Biochemistry, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA.
Jun QinDepartment of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Paul L FoxDepartment of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Thomas A HamiltonDepartment of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.ORCID 0000-0002-9817-242X
Donna DriscollDepartment of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Xiaoxia LiDepartment of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA. lix@ccf.org.ORCID 0000-0002-4872-9525
Cleveland Clinic · USCleveland Clinic Lerner College of Medicine · USJagiellonian University · PLCase Western Reserve University · USCleveland Foundation · US

Funding

TELOMERASE INACTIVATION BY RNASE L SIGNALS CELL DEATHP01CA062220 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI LI, XIAOXIA, STARK, GEORGE ROBERT · 1994 to 2020
$35.6M
Vascular Cell function and AtherosclerosisP01HL029582 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI FOX, PAUL L · 1985 to 2019
$32.0M
Targeting pathological hyaluronan matricesP01HL103453 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI REIZES, OFER · 2011 to 2020
$26.8M
Airway redox biochemistry as a deteriminant of asthma phenotype during adolescen*U10HL109250 · NHLBI · UNIVERSITY OF VIRGINIA · PI ERZURUM, SERPIL C., GASTON, BENJAMIN · 2011 to 2016
$4.2M
NCI NIH HHS P01 CA062220NHLBI NIH HHS P01 HL029582NHLBI NIH HHS P01 HL103453NHLBI NIH HHS U10 HL109250
6 · The paper itself

Abstract

Mechanisms that degrade inflammatory mRNAs are well known; however, stabilizing mechanisms are poorly understood. Here, we show that Act1, an interleukin-17 (IL-17)-receptor-complex adaptor, binds and stabilizes mRNAs encoding key inflammatory proteins. The Act1 SEFIR domain binds a stem-loop structure, the SEFIR-binding element (SBE), in the 3' untranslated region (UTR) of Cxcl1 mRNA, encoding an inflammatory chemokine. mRNA-bound Act1 directs formation of three compartmentally distinct RNA-protein complexes (RNPs) that regulate three disparate events in inflammatory-mRNA metabolism: preventing mRNA decay in the nucleus, inhibiting mRNA decapping in P bodies and promoting translation. SBE RNA aptamers decreased IL-17-mediated mRNA stabilization in vitro, IL-17-induced skin inflammation and airway inflammation in a mouse asthma model, thus providing a therapeutic strategy for autoimmune diseases. These results reveal a network in which Act1 assembles RNPs on the 3' UTRs of select mRNAs and consequently controls receptor-mediated mRNA stabilization and translation during inflammation.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsGene Expression RegulationInflammationInterleukin-17MiceMice, Inbred C57BLReceptors, Interleukin-17RNA, MessengerRNA StabilitySignal TransductionAdaptor Proteins, Signal TransducingInterleukin-17Receptors, Interleukin-17RNA, MessengerTraf3ip2 protein, mouse

Identifiers

PMID29563620
PMCPMC6082628
OpenAlexW2792953869

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.